Cargando…

Valproic acid disables the Nrf2 anti-oxidant response in acute myeloid leukaemia cells enhancing reactive oxygen species-mediated killing

BACKGROUND: We previously demonstrated the in vitro killing of AML cells by the combination of the lipid-lowering agent bezafibrate (BEZ) and the contraceptive hormone medroxyprogesterone acetate (MPA). A phase II trial demonstrated in vivo safety and efficacy of BEZ and MPA (BaP) in elderly, relaps...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Yao, Southam, Andrew D., Trova, Sandro, Beke, Flavio, Alhazmi, Bader, Francis, Thomas, Radotra, Anshul, di Maio, Alessandro, Drayson, Mark T., Bunce, Chris M., Khanim, Farhat L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8770569/ https://www.ncbi.nlm.nih.gov/pubmed/34686779 http://dx.doi.org/10.1038/s41416-021-01570-z

Ejemplares similares

Does the pursuit of scientific excellence serve or hamper translational medical research: an historical perspective from hematological malignancies
por: Bunce, Chris M., et al.
Publicado: (2022)

Metabolomic Profiling of Drug Responses in Acute Myeloid Leukaemia Cell Lines
por: Tiziani, Stefano, et al.
Publicado: (2009)

Correction: Metabolomic Profiling of Drug Responses in Acute Myeloid Leukaemia Cell Lines
por: Tiziani, Stefano, et al.
Publicado: (2009)

Combined bezafibrate, medroxyprogesterone acetate and valproic acid treatment inhibits osteosarcoma cell growth without adversely affecting normal mesenchymal stem cells
por: Sheard, Jonathan J., et al.
Publicado: (2021)

Malonate as a ROS product is associated with pyruvate carboxylase activity in acute myeloid leukaemia cells
por: Reed, Michelle A. C., et al.
Publicado: (2016)

Combined Bezafibrate and Medroxyprogesterone Acetate: Potential Novel Therapy for Acute Myeloid Leukaemia
por: Khanim, Farhat L., et al.
Publicado: (2009)

Pathogen and human NDPK-proteins promote AML cell survival via monocyte NLRP3-inflammasome activation
por: Trova, Sandro, et al.
Publicado: (2023)

Tracer‐Based Metabolic NMR‐Based Flux Analysis in a Leukaemia Cell Line
por: Carrigan, John B., et al.
Publicado: (2016)

Hypoxia Triggers Major Metabolic Changes in AML Cells without Altering Indomethacin-Induced TCA Cycle Deregulation
por: Lodi, Alessia, et al.
Publicado: (2010)

Single arm phase II trial assessing the safety, compliance with and activity of Bezafibrate and medroxyProgesterone acetate (BaP) therapy against myeloid and lymphoid cancers
por: Murray, Jim, et al.
Publicado: (2019)

Proton NMR-Based Metabolite Analyses of Archived Serial Paired Serum and Urine Samples from Myeloma Patients at Different Stages of Disease Activity Identifies Acetylcarnitine as a Novel Marker of Active Disease
por: Lodi, Alessia, et al.
Publicado: (2013)

Hydroxyurea synergizes with valproic acid in wild-type p53 acute myeloid leukaemia
por: Leitch, Calum, et al.
Publicado: (2016)

Analysis of the role of COP9 Signalosome (CSN) subunits in K562; the first link between CSN and autophagy
por: Pearce, Claire, et al.
Publicado: (2009)

Probing the action of a novel anti-leukaemic drug therapy at the single cell level using modern vibrational spectroscopy techniques
por: Denbigh, Joanna L., et al.
Publicado: (2017)

Oxidative Stress Responses and NRF2 in Human Leukaemia
por: Abdul-Aziz, Amina, et al.
Publicado: (2015)

Valproic Acid Sensitizes Hepatocellular Carcinoma Cells to Proton Therapy by Suppressing NRF2 Activation
por: Yu, Jeong Il, et al.
Publicado: (2017)

Combination of curaxin and tyrosine kinase inhibitors display enhanced killing of primitive Chronic Myeloid Leukaemia cells
por: Pearson, Stella, et al.
Publicado: (2022)

Dissecting racial disparities in multiple myeloma—clues from differential immunoglobulin levels
por: Bunce, C. M., et al.
Publicado: (2020)

Antagonism of drugs used in leukaemia therapy to the killing of human lymphoblastoid cells by steroid.
por: Gledhill, R. M., et al.
Publicado: (1981)

Redeployment-based drug screening identifies the anti-helminthic niclosamide as anti-myeloma therapy that also reduces free light chain production
por: Khanim, F L, et al.
Publicado: (2011)

Metabolic plasticity in CLL: adaptation to the hypoxic niche
por: Koczula, K M, et al.
Publicado: (2016)

Bullous Diabeticorum: A Rare Blistering Manifestation of Diabetes
por: Chatterjee, Debajyoti, et al.
Publicado: (2017)

Publisher Correction: Valproic Acid Sensitizes Hepatocellular Carcinoma Cells to Proton Therapy by Suppressing NRF2 Activation
por: Yu, Jeong Il, et al.
Publicado: (2018)

Synergistic apoptotic response between valproic acid and fludarabine in chronic lymphocytic leukaemia (CLL) cells involves the lysosomal protease cathepsin B
por: Yoon, J-Y, et al.
Publicado: (2013)

Valproic Acid Attenuates Traumatic Brain Injury-Induced Inflammation in Vivo: Involvement of Autophagy and the Nrf2/ARE Signaling Pathway
por: Chen, Xiangrong, et al.
Publicado: (2018)

Possible association between moderate intellectual disability and weight gain in valproic acid–treated patients with epilepsy
por: Tanamachi, Yukiko, et al.
Publicado: (2015)

Identification of NRF2 Activation as a Prognostic Biomarker in T-Cell Acute Lymphoblastic Leukaemia
por: Villa-Morales, María, et al.
Publicado: (2023)

Invariant NKT cells metabolically adapt to the acute myeloid leukaemia environment
por: Stavrou, Victoria, et al.
Publicado: (2022)

Selective AKR1C3 inhibitors do not recapitulate the anti-leukaemic activities of the pan-AKR1C inhibitor medroxyprogesterone acetate
por: Khanim, F, et al.
Publicado: (2014)

Development of a nano-luciferase based assay to measure the binding of SARS-CoV-2 spike receptor binding domain to ACE-2
por: Lima, Marcelo A., et al.
Publicado: (2021)

Chemotherapy of the Myeloid Leukaemias
por: Stuart, John
Publicado: (1980)

Monoclonal gammopathy of increasing significance: time to screen?
por: Chen, Lucia Y., et al.
Publicado: (2022)

Primary Cutaneous Nodular Amyloidosis: A Rare Disease
por: Chatterjee, Debajyoti, et al.
Publicado: (2017)

Screening a library of approved drugs reveals that prednisolone synergizes with pitavastatin to induce ovarian cancer cell death
por: Abdullah, Marwan Ibrahim, et al.
Publicado: (2019)

Angioedema induced by valproic acid
por: Yildiz, Sevler, et al.
Publicado: (2021)

Acute Myeloid Leukaemia in Its Niche: the Bone Marrow Microenvironment in Acute Myeloid Leukaemia
por: Ladikou, E. E., et al.
Publicado: (2020)

Human leukaemia: recent tissue culture studies on the nature of myeloid leukaemia.
por: Metcalf, D.
Publicado: (1973)

IL-8 as mediator in the microenvironment-leukaemia network in acute myeloid leukaemia
por: Kuett, Alexander, et al.
Publicado: (2015)

Biochemical and Molecular Analysis of the Hb Lepore Boston Washington in a Syrian Homozygous Child
por: Pirastru, Monica, et al.
Publicado: (2017)

Erythropoiesis in Murine Myeloid Leukaemia
por: Tanaka, T.
Publicado: (1970)

Cannot write session to /tmp/vufind_sessions/sess_c0skr1je3fph1334f4dk96krf3